Skip to main content

Table 1 Patient characteristics

From: Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories

Characteristic

Entire Group (n = 30)

Age (years)

57 ± 11

Male gender

24 (80%)

Vital Parameters

 Systolic Blood Pressure (mmHg)

131 ± 24

 Diastolic Blood Pressure (mmHg)

78 ± 17

 Height (cm)

173 ± 12

 Weight (kg)

85 ± 14

CAD Risk Factors

 Diabetes mellitus

10 (33%)

 Hypertension

17 (57%)

 Family History of CAD

7 (23%)

 Current Smoker

13 (43%)

 Hyperlipidemia

14 (47%)

Medications

 Statins

30 (100%)

 Beta-blockers

30 (100%)

 Aspirin

30 (100%)

 Thienopyridine

30 (100%)

 ACE-I or ARB

30 (100%)

Peak Troponin

 Troponin T, ng/ml (n = 25)

7.3 ± 4.5

 Troponin I, ng/ml (n = 5)

39.6 ± 18.2

Primary Treatment

 PCI

28 (94%)a

 Lytics

1 (3%)

 None

1 (3%)b

Infarct Related Artery

 LAD

13 (43%)

 RCA

12 (40%)

 LCx

5 (17%)

  1. CAD coronary artery disease, ACE-inhibitor angiotensin-converting-enzyme inhibitor, PCI percutaneous coronary intervention, LAD left anterior descending coronary artery, RCA right coronary artery, LCx left circumflex coronary artery
  2. aIn 2 patients PCI was not successful
  3. bPresented later than 24 h